The CLARITY Trial Lead by Dr. Hillmen Feasibility study that looked at efficacy of Ibrutnib and Venetolax in RR-CLL - 100459

Spotlight
Video

The CLARITY Trial Lead by Dr. Hillmen Feasibility study that looked at efficacy of Ibrutnib and Venetolax in RR-CLL

moasc has 295 videos Subscribe Here

Loading........
Description: Dr. Ann Eapen Division of Hematology/Oncology: UC Irvine discusses The CLARITY Trial Lead by Dr. Hillmen Feasibility study that looked at efficacy of Ibrutnib and Venetolax in RR-CLL at MOASC’s Spotlight On Hematology in Huntington Beach 2018.
Shared By : moasc
Posted on : 02/06/18
Added : 5 months ago



Recommended

Nothing found.